-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Since 2021, the reform of the domestic pharmaceutical industry has further deepened.
In this context, many pharmaceutical companies have accelerated their transformation and upgrading, with continuous new actions and a significant increase in the flow of executives
.
The author understands that until the end of 2021, there will still be a group of senior executives of pharmaceutical companies "going out", mainly for personal reasons
.
Pfizer China: Chief Operating Officer Will Resign On December 30th, Pfizer China Chief Operating Officer Wu Kun is about to leave
.
Public information shows that Wu Kun has worked for the company for 26 years since joining Pfizer in 1995.
He has held a series of positions in the sales and marketing department, including regional manager, regional manager, national sales director, marketing director, and basic medical care.
Acting general manager of the division
.
Aoyuan Meigu: A number of executives "leave" Aoyuan Meigu announced on the evening of December 29 that the company's board of directors received the resignation report from Chairman Ma Jun, Director Chen Yong, Independent Director Zhang Shujun, President Hu Ran, and Executive President Fan Shijie
.
After resignation, Ma Jun, Chen Yong, and Zhang Shujun will not hold any positions in the company, Hu Ran will continue to serve as directors of the company, and Fan Shijie will continue to serve as employee directors of the company
.
At the same time, the company elected Hu Ran as the company's chairman and agreed to appoint Fan Shijie as the company's president
.
Xiangsheng Medical: Core Technical Staff Resigned On December 29, Xiangsheng Medical issued an announcement stating that the company's core technical staff and senior manager of the R&D Center System Department Mr.
Wang Yong had resigned due to personal reasons and completed the resignation procedures
.
KGI Bio: Many directors resigned.
On December 27, KGI announced that the company’s board of directors received the resignation report from Director Mr.
Pan Xingcai and Director Ms.
Mo Meiyan on December 24, 2021.
Mr.
Pan Xingcai and Mo Mei Ms.
Yan resigned from the board of directors due to personal reasons
.
The company stated that its resignation as a director of the board of directors will not have any adverse effects on the company's production and business activities
.
Eddie Pharmaceuticals: Resignation of core technical personnel On December 25, Eddie Pharmaceuticals issued multiple announcements involving the resignation of 2 core technical personnel
.
It is reported that these two core technicians have participated in the research and development process of multiple anti-tumor drugs of Aidi Pharmaceuticals
.
Technical director and core technicians Li Wenquan and Hu Xionglin mainly participated in the research and development of new anti-tumor drugs ACC006 and ACC010 and new anti-AIDS drugs ACC007 and ACC008
.
Among them, Hu Xionglin has participated in the research of Aidi Pharmaceuticals' AIDS drug Aibond and played an important role
.
Wan'an Pharmaceutical: Director's Resignation Wan'an Pharmaceutical announced on December 23 that the company's board of directors received a resignation report from director Mr.
Li Zhihao on December 23, 2021.
Mr.
Li Zhihao resigned as a director due to personal reasons
.
The resignation of Mr.
Li Zhihao as a director of the company will not have a negative impact on the company's production and operation, and will not affect the normal progress of the company's related work
.
At the same time, the company said it would elect new directors as soon as possible
.
In order to ensure the normal work of the board of directors, Mr.
Li Zhihao will continue to perform his duties as a director before the company’s general meeting of shareholders elects new directors
.
ST Wanyao: Director's resignation On December 23, ST Wanyao announced that the company's board of directors received a resignation report from director Mr.
Li Zhihao on December 23, 2021, and the resignation took effect from the day when the new director was elected by the general meeting of shareholders
.
Mr.
Li Zhihao resigned as director due to personal reasons
.
In this context, many pharmaceutical companies have accelerated their transformation and upgrading, with continuous new actions and a significant increase in the flow of executives
.
The author understands that until the end of 2021, there will still be a group of senior executives of pharmaceutical companies "going out", mainly for personal reasons
.
Pfizer China: Chief Operating Officer Will Resign On December 30th, Pfizer China Chief Operating Officer Wu Kun is about to leave
.
Public information shows that Wu Kun has worked for the company for 26 years since joining Pfizer in 1995.
He has held a series of positions in the sales and marketing department, including regional manager, regional manager, national sales director, marketing director, and basic medical care.
Acting general manager of the division
.
Aoyuan Meigu: A number of executives "leave" Aoyuan Meigu announced on the evening of December 29 that the company's board of directors received the resignation report from Chairman Ma Jun, Director Chen Yong, Independent Director Zhang Shujun, President Hu Ran, and Executive President Fan Shijie
.
After resignation, Ma Jun, Chen Yong, and Zhang Shujun will not hold any positions in the company, Hu Ran will continue to serve as directors of the company, and Fan Shijie will continue to serve as employee directors of the company
.
At the same time, the company elected Hu Ran as the company's chairman and agreed to appoint Fan Shijie as the company's president
.
Xiangsheng Medical: Core Technical Staff Resigned On December 29, Xiangsheng Medical issued an announcement stating that the company's core technical staff and senior manager of the R&D Center System Department Mr.
Wang Yong had resigned due to personal reasons and completed the resignation procedures
.
KGI Bio: Many directors resigned.
On December 27, KGI announced that the company’s board of directors received the resignation report from Director Mr.
Pan Xingcai and Director Ms.
Mo Meiyan on December 24, 2021.
Mr.
Pan Xingcai and Mo Mei Ms.
Yan resigned from the board of directors due to personal reasons
.
The company stated that its resignation as a director of the board of directors will not have any adverse effects on the company's production and business activities
.
Eddie Pharmaceuticals: Resignation of core technical personnel On December 25, Eddie Pharmaceuticals issued multiple announcements involving the resignation of 2 core technical personnel
.
It is reported that these two core technicians have participated in the research and development process of multiple anti-tumor drugs of Aidi Pharmaceuticals
.
Technical director and core technicians Li Wenquan and Hu Xionglin mainly participated in the research and development of new anti-tumor drugs ACC006 and ACC010 and new anti-AIDS drugs ACC007 and ACC008
.
Among them, Hu Xionglin has participated in the research of Aidi Pharmaceuticals' AIDS drug Aibond and played an important role
.
Wan'an Pharmaceutical: Director's Resignation Wan'an Pharmaceutical announced on December 23 that the company's board of directors received a resignation report from director Mr.
Li Zhihao on December 23, 2021.
Mr.
Li Zhihao resigned as a director due to personal reasons
.
The resignation of Mr.
Li Zhihao as a director of the company will not have a negative impact on the company's production and operation, and will not affect the normal progress of the company's related work
.
At the same time, the company said it would elect new directors as soon as possible
.
In order to ensure the normal work of the board of directors, Mr.
Li Zhihao will continue to perform his duties as a director before the company’s general meeting of shareholders elects new directors
.
ST Wanyao: Director's resignation On December 23, ST Wanyao announced that the company's board of directors received a resignation report from director Mr.
Li Zhihao on December 23, 2021, and the resignation took effect from the day when the new director was elected by the general meeting of shareholders
.
Mr.
Li Zhihao resigned as director due to personal reasons
.
